6533b7d0fe1ef96bd125b3c0
RESEARCH PRODUCT
The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars
Mazzoni D.Vener C.Mazzocco K.Monzani D.Pravettoni G.subject
oncologyshared decision-makingnocebo effectrheumatologyadherencedescription
Biological products are therapeutic agents produced using a living system or organism. In many cases, access to these products is limited due to their expensive cost (Chow et al., 2011). A biosimilar is a biological product that is highly similar (not identic) to, and has no clinically meaningful differences from, an existing reference biological product on the market (Desai et al., 2020). “Non-medical” switching is the switching of a patient's medicine for reasons other than the patient's health and safety, like the reduction of costs (Dolinar et al., 2019).
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-01-01 |